NanoVibronix, Inc.
NanoVibronix, Inc. (NAOV) Stock Competitors & Peer Comparison
See (NAOV) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NAOV | $8.34 | +942.37% | 2M | -0.01 | -$153.30 | N/A |
| ABT | $130.93 | -2.49% | 228.8B | 16.47 | $7.98 | +1.76% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| BSX | $102.95 | -0.18% | 152.2B | 61.16 | $1.68 | N/A |
| SYK | $374.94 | -0.70% | 144B | 49.89 | $7.55 | +0.88% |
| MDT | $89.36 | -3.79% | 118.8B | 25.69 | $3.61 | +3.03% |
| EW | $78.61 | +0.33% | 45.9B | 32.72 | $2.39 | N/A |
| DXCM | $76.40 | -3.12% | 30.5B | 54.82 | $1.42 | N/A |
| PHG | $26.20 | -2.38% | 25.4B | 140.37 | $0.19 | +3.32% |
| STE | $221.21 | -8.91% | 23.8B | 37.01 | $6.53 | +0.94% |
Stock Comparison
NAOV vs ABT Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, ABT has a market cap of 228.8B. Regarding current trading prices, NAOV is priced at $8.34, while ABT trades at $130.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas ABT's P/E ratio is 16.47. In terms of profitability, NAOV's ROE is -0.55%, compared to ABT's ROE of +0.32%. Regarding short-term risk, NAOV is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check ABT's competition here
NAOV vs BSX-PA Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, NAOV is priced at $8.34, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, NAOV's ROE is -0.55%, compared to BSX-PA's ROE of +0.12%. Regarding short-term risk, NAOV is more volatile compared to BSX-PA. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check BSX-PA's competition here
NAOV vs BSX Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, BSX has a market cap of 152.2B. Regarding current trading prices, NAOV is priced at $8.34, while BSX trades at $102.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas BSX's P/E ratio is 61.16. In terms of profitability, NAOV's ROE is -0.55%, compared to BSX's ROE of +0.12%. Regarding short-term risk, NAOV is more volatile compared to BSX. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check BSX's competition here
NAOV vs SYK Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, SYK has a market cap of 144B. Regarding current trading prices, NAOV is priced at $8.34, while SYK trades at $374.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas SYK's P/E ratio is 49.89. In terms of profitability, NAOV's ROE is -0.55%, compared to SYK's ROE of +0.14%. Regarding short-term risk, NAOV is more volatile compared to SYK. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check SYK's competition here
NAOV vs MDT Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, MDT has a market cap of 118.8B. Regarding current trading prices, NAOV is priced at $8.34, while MDT trades at $89.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas MDT's P/E ratio is 25.69. In terms of profitability, NAOV's ROE is -0.55%, compared to MDT's ROE of +0.10%. Regarding short-term risk, NAOV is more volatile compared to MDT. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check MDT's competition here
NAOV vs EW Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, EW has a market cap of 45.9B. Regarding current trading prices, NAOV is priced at $8.34, while EW trades at $78.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas EW's P/E ratio is 32.72. In terms of profitability, NAOV's ROE is -0.55%, compared to EW's ROE of +0.41%. Regarding short-term risk, NAOV is more volatile compared to EW. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check EW's competition here
NAOV vs DXCM Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, DXCM has a market cap of 30.5B. Regarding current trading prices, NAOV is priced at $8.34, while DXCM trades at $76.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas DXCM's P/E ratio is 54.82. In terms of profitability, NAOV's ROE is -0.55%, compared to DXCM's ROE of +0.26%. Regarding short-term risk, NAOV is more volatile compared to DXCM. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check DXCM's competition here
NAOV vs PHG Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, PHG has a market cap of 25.4B. Regarding current trading prices, NAOV is priced at $8.34, while PHG trades at $26.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas PHG's P/E ratio is 140.37. In terms of profitability, NAOV's ROE is -0.55%, compared to PHG's ROE of +0.01%. Regarding short-term risk, NAOV is more volatile compared to PHG. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check PHG's competition here
NAOV vs STE Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, STE has a market cap of 23.8B. Regarding current trading prices, NAOV is priced at $8.34, while STE trades at $221.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas STE's P/E ratio is 37.01. In terms of profitability, NAOV's ROE is -0.55%, compared to STE's ROE of +0.10%. Regarding short-term risk, NAOV is more volatile compared to STE. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check STE's competition here
NAOV vs PODD Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, PODD has a market cap of 21.5B. Regarding current trading prices, NAOV is priced at $8.34, while PODD trades at $277.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas PODD's P/E ratio is 92.66. In terms of profitability, NAOV's ROE is -0.55%, compared to PODD's ROE of +0.21%. Regarding short-term risk, NAOV is more volatile compared to PODD. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check PODD's competition here
NAOV vs ZBH Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, ZBH has a market cap of 19.8B. Regarding current trading prices, NAOV is priced at $8.34, while ZBH trades at $91.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas ZBH's P/E ratio is 24.40. In terms of profitability, NAOV's ROE is -0.55%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, NAOV is more volatile compared to ZBH. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check ZBH's competition here
NAOV vs ABMD Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, NAOV is priced at $8.34, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas ABMD's P/E ratio is 65.36. In terms of profitability, NAOV's ROE is -0.55%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, NAOV is more volatile compared to ABMD. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check ABMD's competition here
NAOV vs SNN Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, SNN has a market cap of 15.7B. Regarding current trading prices, NAOV is priced at $8.34, while SNN trades at $35.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas SNN's P/E ratio is 32.12. In terms of profitability, NAOV's ROE is -0.55%, compared to SNN's ROE of +0.09%. Regarding short-term risk, NAOV is more volatile compared to SNN. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check SNN's competition here
NAOV vs SWAV Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, NAOV is priced at $8.34, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas SWAV's P/E ratio is 78.76. In terms of profitability, NAOV's ROE is -0.55%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, NAOV is more volatile compared to SWAV. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check SWAV's competition here
NAOV vs ALGN Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, ALGN has a market cap of 9.8B. Regarding current trading prices, NAOV is priced at $8.34, while ALGN trades at $136.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas ALGN's P/E ratio is 22.77. In terms of profitability, NAOV's ROE is -0.55%, compared to ALGN's ROE of +0.11%. Regarding short-term risk, NAOV is more volatile compared to ALGN. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check ALGN's competition here
NAOV vs PEN Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, PEN has a market cap of 9.4B. Regarding current trading prices, NAOV is priced at $8.34, while PEN trades at $239.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas PEN's P/E ratio is 63.46. In terms of profitability, NAOV's ROE is -0.55%, compared to PEN's ROE of +0.12%. Regarding short-term risk, NAOV is more volatile compared to PEN. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check PEN's competition here
NAOV vs GMED Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, GMED has a market cap of 8B. Regarding current trading prices, NAOV is priced at $8.34, while GMED trades at $52.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas GMED's P/E ratio is 44.36. In terms of profitability, NAOV's ROE is -0.55%, compared to GMED's ROE of +0.09%. Regarding short-term risk, NAOV is more volatile compared to GMED. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check GMED's competition here
NAOV vs BIO Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, BIO has a market cap of 7.2B. Regarding current trading prices, NAOV is priced at $8.34, while BIO trades at $264.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas BIO's P/E ratio is 23.80. In terms of profitability, NAOV's ROE is -0.55%, compared to BIO's ROE of +0.05%. Regarding short-term risk, NAOV is more volatile compared to BIO. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check BIO's competition here
NAOV vs BIO-B Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, BIO-B has a market cap of 6.7B. Regarding current trading prices, NAOV is priced at $8.34, while BIO-B trades at $247.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas BIO-B's P/E ratio is -3.23. In terms of profitability, NAOV's ROE is -0.55%, compared to BIO-B's ROE of +0.05%. Regarding short-term risk, NAOV is more volatile compared to BIO-B. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check BIO-B's competition here
NAOV vs IRTC Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, IRTC has a market cap of 5.2B. Regarding current trading prices, NAOV is priced at $8.34, while IRTC trades at $156.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas IRTC's P/E ratio is -54.99. In terms of profitability, NAOV's ROE is -0.55%, compared to IRTC's ROE of -1.05%. Regarding short-term risk, NAOV is more volatile compared to IRTC. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check IRTC's competition here
NAOV vs GKOS Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, GKOS has a market cap of 5B. Regarding current trading prices, NAOV is priced at $8.34, while GKOS trades at $88.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas GKOS's P/E ratio is -54.02. In terms of profitability, NAOV's ROE is -0.55%, compared to GKOS's ROE of -0.13%. Regarding short-term risk, NAOV is more volatile compared to GKOS. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check GKOS's competition here
NAOV vs NARI Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, NAOV is priced at $8.34, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas NARI's P/E ratio is -59.24. In terms of profitability, NAOV's ROE is -0.55%, compared to NARI's ROE of -0.17%. Regarding short-term risk, NAOV is more volatile compared to NARI. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check NARI's competition here
NAOV vs BRKR Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, BRKR has a market cap of 4.7B. Regarding current trading prices, NAOV is priced at $8.34, while BRKR trades at $30.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas BRKR's P/E ratio is 59.19. In terms of profitability, NAOV's ROE is -0.55%, compared to BRKR's ROE of +0.04%. Regarding short-term risk, NAOV is more volatile compared to BRKR. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check BRKR's competition here
NAOV vs TMDX Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, TMDX has a market cap of 4.3B. Regarding current trading prices, NAOV is priced at $8.34, while TMDX trades at $118.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas TMDX's P/E ratio is 63.95. In terms of profitability, NAOV's ROE is -0.55%, compared to TMDX's ROE of +0.28%. Regarding short-term risk, NAOV is more volatile compared to TMDX. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check TMDX's competition here
NAOV vs ITGR Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, ITGR has a market cap of 3.7B. Regarding current trading prices, NAOV is priced at $8.34, while ITGR trades at $105.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas ITGR's P/E ratio is 45.08. In terms of profitability, NAOV's ROE is -0.55%, compared to ITGR's ROE of +0.05%. Regarding short-term risk, NAOV is more volatile compared to ITGR. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check ITGR's competition here
NAOV vs AXNX Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, NAOV is priced at $8.34, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas AXNX's P/E ratio is -709.80. In terms of profitability, NAOV's ROE is -0.55%, compared to AXNX's ROE of -0.02%. Regarding short-term risk, NAOV is more volatile compared to AXNX. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check AXNX's competition here
NAOV vs LIVN Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, LIVN has a market cap of 2.7B. Regarding current trading prices, NAOV is priced at $8.34, while LIVN trades at $47.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas LIVN's P/E ratio is -12.77. In terms of profitability, NAOV's ROE is -0.55%, compared to LIVN's ROE of -0.18%. Regarding short-term risk, NAOV is more volatile compared to LIVN. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check LIVN's competition here
NAOV vs INSP Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, INSP has a market cap of 2.4B. Regarding current trading prices, NAOV is priced at $8.34, while INSP trades at $78.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas INSP's P/E ratio is 45.75. In terms of profitability, NAOV's ROE is -0.55%, compared to INSP's ROE of +0.08%. Regarding short-term risk, NAOV is less volatile compared to INSP. This indicates potentially lower risk in terms of short-term price fluctuations for NAOV.Check INSP's competition here
NAOV vs ATEC Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, ATEC has a market cap of 2.3B. Regarding current trading prices, NAOV is priced at $8.34, while ATEC trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas ATEC's P/E ratio is -13.56. In terms of profitability, NAOV's ROE is -0.55%, compared to ATEC's ROE of -2.52%. Regarding short-term risk, NAOV is more volatile compared to ATEC. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check ATEC's competition here
NAOV vs PRCT Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, PRCT has a market cap of 2.2B. Regarding current trading prices, NAOV is priced at $8.34, while PRCT trades at $45.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas PRCT's P/E ratio is -25.18. In terms of profitability, NAOV's ROE is -0.55%, compared to PRCT's ROE of -0.24%. Regarding short-term risk, NAOV is more volatile compared to PRCT. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check PRCT's competition here
NAOV vs NUVA Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, NAOV is priced at $8.34, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas NUVA's P/E ratio is 75.00. In terms of profitability, NAOV's ROE is -0.55%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, NAOV is more volatile compared to NUVA. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check NUVA's competition here
NAOV vs AORT Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, AORT has a market cap of 1.8B. Regarding current trading prices, NAOV is priced at $8.34, while AORT trades at $32.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas AORT's P/E ratio is -99.97. In terms of profitability, NAOV's ROE is -0.55%, compared to AORT's ROE of -0.06%. Regarding short-term risk, NAOV is more volatile compared to AORT. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check AORT's competition here
NAOV vs UFPT Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, UFPT has a market cap of 1.6B. Regarding current trading prices, NAOV is priced at $8.34, while UFPT trades at $213.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas UFPT's P/E ratio is 24.84. In terms of profitability, NAOV's ROE is -0.55%, compared to UFPT's ROE of +0.19%. Regarding short-term risk, NAOV is less volatile compared to UFPT. This indicates potentially lower risk in terms of short-term price fluctuations for NAOV.Check UFPT's competition here
NAOV vs CNMD Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, CNMD has a market cap of 1.6B. Regarding current trading prices, NAOV is priced at $8.34, while CNMD trades at $51.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas CNMD's P/E ratio is 14.83. In terms of profitability, NAOV's ROE is -0.55%, compared to CNMD's ROE of +0.11%. Regarding short-term risk, NAOV is more volatile compared to CNMD. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check CNMD's competition here
NAOV vs HSKA Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, NAOV is priced at $8.34, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas HSKA's P/E ratio is -62.49. In terms of profitability, NAOV's ROE is -0.55%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, NAOV is more volatile compared to HSKA. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check HSKA's competition here
NAOV vs AHCO Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, AHCO has a market cap of 1.3B. Regarding current trading prices, NAOV is priced at $8.34, while AHCO trades at $9.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas AHCO's P/E ratio is 17.28. In terms of profitability, NAOV's ROE is -0.55%, compared to AHCO's ROE of +0.05%. Regarding short-term risk, NAOV is more volatile compared to AHCO. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check AHCO's competition here
NAOV vs SSII Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, SSII has a market cap of 1.2B. Regarding current trading prices, NAOV is priced at $8.34, while SSII trades at $6.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas SSII's P/E ratio is -104.50. In terms of profitability, NAOV's ROE is -0.55%, compared to SSII's ROE of -1.05%. Regarding short-term risk, NAOV is more volatile compared to SSII. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check SSII's competition here
NAOV vs SILK Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, NAOV is priced at $8.34, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas SILK's P/E ratio is -18.96. In terms of profitability, NAOV's ROE is -0.55%, compared to SILK's ROE of -0.20%. Regarding short-term risk, NAOV is more volatile compared to SILK. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check SILK's competition here
NAOV vs FNA Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, NAOV is priced at $8.34, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas FNA's P/E ratio is -19.83. In terms of profitability, NAOV's ROE is -0.55%, compared to FNA's ROE of -0.36%. Regarding short-term risk, NAOV is more volatile compared to FNA. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check FNA's competition here
NAOV vs IART Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, IART has a market cap of 993.4M. Regarding current trading prices, NAOV is priced at $8.34, while IART trades at $12.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas IART's P/E ratio is -1.95. In terms of profitability, NAOV's ROE is -0.55%, compared to IART's ROE of -0.36%. Regarding short-term risk, NAOV is more volatile compared to IART. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check IART's competition here
NAOV vs ESTA Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, ESTA has a market cap of 970.5M. Regarding current trading prices, NAOV is priced at $8.34, while ESTA trades at $41.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas ESTA's P/E ratio is -10.90. In terms of profitability, NAOV's ROE is -0.55%, compared to ESTA's ROE of -2.41%. Regarding short-term risk, NAOV is more volatile compared to ESTA. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check ESTA's competition here
NAOV vs INMD Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, INMD has a market cap of 959.9M. Regarding current trading prices, NAOV is priced at $8.34, while INMD trades at $13.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas INMD's P/E ratio is 5.80. In terms of profitability, NAOV's ROE is -0.55%, compared to INMD's ROE of +0.27%. Regarding short-term risk, NAOV is more volatile compared to INMD. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check INMD's competition here
NAOV vs IRMD Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, IRMD has a market cap of 890.4M. Regarding current trading prices, NAOV is priced at $8.34, while IRMD trades at $70.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas IRMD's P/E ratio is 43.48. In terms of profitability, NAOV's ROE is -0.55%, compared to IRMD's ROE of +0.24%. Regarding short-term risk, NAOV is more volatile compared to IRMD. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check IRMD's competition here
NAOV vs CSII Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, NAOV is priced at $8.34, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas CSII's P/E ratio is -20.83. In terms of profitability, NAOV's ROE is -0.55%, compared to CSII's ROE of -0.14%. Regarding short-term risk, NAOV is more volatile compared to CSII. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check CSII's competition here
NAOV vs CRY Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, CRY has a market cap of 725.1M. Regarding current trading prices, NAOV is priced at $8.34, while CRY trades at $17.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas CRY's P/E ratio is 425.71. In terms of profitability, NAOV's ROE is -0.55%, compared to CRY's ROE of -0.06%. Regarding short-term risk, NAOV is more volatile compared to CRY. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check CRY's competition here
NAOV vs TNDM Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, TNDM has a market cap of 683.5M. Regarding current trading prices, NAOV is priced at $8.34, while TNDM trades at $14.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas TNDM's P/E ratio is -3.28. In terms of profitability, NAOV's ROE is -0.55%, compared to TNDM's ROE of -1.04%. Regarding short-term risk, NAOV is more volatile compared to TNDM. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check TNDM's competition here
NAOV vs SIBN Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, SIBN has a market cap of 664.4M. Regarding current trading prices, NAOV is priced at $8.34, while SIBN trades at $16.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas SIBN's P/E ratio is -27.02. In terms of profitability, NAOV's ROE is -0.55%, compared to SIBN's ROE of -0.14%. Regarding short-term risk, NAOV is more volatile compared to SIBN. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check SIBN's competition here
NAOV vs AXGN Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, AXGN has a market cap of 644.6M. Regarding current trading prices, NAOV is priced at $8.34, while AXGN trades at $13.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas AXGN's P/E ratio is -140.10. In terms of profitability, NAOV's ROE is -0.55%, compared to AXGN's ROE of -0.04%. Regarding short-term risk, NAOV is more volatile compared to AXGN. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check AXGN's competition here
NAOV vs APEN Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, NAOV is priced at $8.34, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas APEN's P/E ratio is -9.43. In terms of profitability, NAOV's ROE is -0.55%, compared to APEN's ROE of -0.85%. Regarding short-term risk, NAOV is more volatile compared to APEN. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check APEN's competition here
NAOV vs SRDX Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, SRDX has a market cap of 543.4M. Regarding current trading prices, NAOV is priced at $8.34, while SRDX trades at $35.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas SRDX's P/E ratio is -27.14. In terms of profitability, NAOV's ROE is -0.55%, compared to SRDX's ROE of -0.16%. Regarding short-term risk, NAOV is more volatile compared to SRDX. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check SRDX's competition here
NAOV vs ZIMV Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, ZIMV has a market cap of 531M. Regarding current trading prices, NAOV is priced at $8.34, while ZIMV trades at $18.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas ZIMV's P/E ratio is -27.29. In terms of profitability, NAOV's ROE is -0.55%, compared to ZIMV's ROE of -0.05%. Regarding short-term risk, NAOV is more volatile compared to ZIMV. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check ZIMV's competition here
NAOV vs SMLR Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, SMLR has a market cap of 522.3M. Regarding current trading prices, NAOV is priced at $8.34, while SMLR trades at $35.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas SMLR's P/E ratio is 7.74. In terms of profitability, NAOV's ROE is -0.55%, compared to SMLR's ROE of +0.17%. Regarding short-term risk, NAOV is more volatile compared to SMLR. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check SMLR's competition here
NAOV vs OFIX Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, OFIX has a market cap of 511.1M. Regarding current trading prices, NAOV is priced at $8.34, while OFIX trades at $12.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas OFIX's P/E ratio is -4.08. In terms of profitability, NAOV's ROE is -0.55%, compared to OFIX's ROE of -0.25%. Regarding short-term risk, NAOV is more volatile compared to OFIX. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check OFIX's competition here
NAOV vs AVNS Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, AVNS has a market cap of 488.2M. Regarding current trading prices, NAOV is priced at $8.34, while AVNS trades at $10.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas AVNS's P/E ratio is -1.05. In terms of profitability, NAOV's ROE is -0.55%, compared to AVNS's ROE of -0.50%. Regarding short-term risk, NAOV is more volatile compared to AVNS. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check AVNS's competition here
NAOV vs CTKB Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, CTKB has a market cap of 482.2M. Regarding current trading prices, NAOV is priced at $8.34, while CTKB trades at $3.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas CTKB's P/E ratio is -75.80. In terms of profitability, NAOV's ROE is -0.55%, compared to CTKB's ROE of -0.02%. Regarding short-term risk, NAOV is more volatile compared to CTKB. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check CTKB's competition here
NAOV vs KIDS Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, KIDS has a market cap of 471.6M. Regarding current trading prices, NAOV is priced at $8.34, while KIDS trades at $17.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas KIDS's P/E ratio is -10.45. In terms of profitability, NAOV's ROE is -0.55%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, NAOV is less volatile compared to KIDS. This indicates potentially lower risk in terms of short-term price fluctuations for NAOV.Check KIDS's competition here
NAOV vs BVS Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, BVS has a market cap of 463.6M. Regarding current trading prices, NAOV is priced at $8.34, while BVS trades at $7.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas BVS's P/E ratio is 231.00. In terms of profitability, NAOV's ROE is -0.55%, compared to BVS's ROE of -0.00%. Regarding short-term risk, NAOV is less volatile compared to BVS. This indicates potentially lower risk in terms of short-term price fluctuations for NAOV.Check BVS's competition here
NAOV vs CBLL Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, CBLL has a market cap of 444.4M. Regarding current trading prices, NAOV is priced at $8.34, while CBLL trades at $12.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas CBLL's P/E ratio is -3.36. In terms of profitability, NAOV's ROE is -0.55%, compared to CBLL's ROE of -0.48%. Regarding short-term risk, NAOV is less volatile compared to CBLL. This indicates potentially lower risk in terms of short-term price fluctuations for NAOV.Check CBLL's competition here
NAOV vs VREX Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, VREX has a market cap of 405.5M. Regarding current trading prices, NAOV is priced at $8.34, while VREX trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas VREX's P/E ratio is -3.02. In terms of profitability, NAOV's ROE is -0.55%, compared to VREX's ROE of -0.25%. Regarding short-term risk, NAOV is more volatile compared to VREX. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check VREX's competition here
NAOV vs TMCI Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, TMCI has a market cap of 403.7M. Regarding current trading prices, NAOV is priced at $8.34, while TMCI trades at $5.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas TMCI's P/E ratio is -8.09. In terms of profitability, NAOV's ROE is -0.55%, compared to TMCI's ROE of -0.47%. Regarding short-term risk, NAOV is more volatile compared to TMCI. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check TMCI's competition here
NAOV vs PACB Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, PACB has a market cap of 378.5M. Regarding current trading prices, NAOV is priced at $8.34, while PACB trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas PACB's P/E ratio is -0.57. In terms of profitability, NAOV's ROE is -0.55%, compared to PACB's ROE of -1.89%. Regarding short-term risk, NAOV is more volatile compared to PACB. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check PACB's competition here
NAOV vs SENS Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, SENS has a market cap of 375.8M. Regarding current trading prices, NAOV is priced at $8.34, while SENS trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas SENS's P/E ratio is -4.61. In terms of profitability, NAOV's ROE is -0.55%, compared to SENS's ROE of -12.27%. Regarding short-term risk, NAOV is more volatile compared to SENS. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check SENS's competition here
NAOV vs SNWV Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, SNWV has a market cap of 366.2M. Regarding current trading prices, NAOV is priced at $8.34, while SNWV trades at $35.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas SNWV's P/E ratio is -6.86. In terms of profitability, NAOV's ROE is -0.55%, compared to SNWV's ROE of +1.45%. Regarding short-term risk, NAOV is more volatile compared to SNWV. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check SNWV's competition here
NAOV vs BFLY Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, BFLY has a market cap of 343.6M. Regarding current trading prices, NAOV is priced at $8.34, while BFLY trades at $1.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas BFLY's P/E ratio is -4.87. In terms of profitability, NAOV's ROE is -0.55%, compared to BFLY's ROE of -0.31%. Regarding short-term risk, NAOV is more volatile compared to BFLY. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check BFLY's competition here
NAOV vs BFLY-WT Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, BFLY-WT has a market cap of 326.4M. Regarding current trading prices, NAOV is priced at $8.34, while BFLY-WT trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas BFLY-WT's P/E ratio is N/A. In terms of profitability, NAOV's ROE is -0.55%, compared to BFLY-WT's ROE of -0.31%. Regarding short-term risk, NAOV is less volatile compared to BFLY-WT. This indicates potentially lower risk in terms of short-term price fluctuations for NAOV.Check BFLY-WT's competition here
NAOV vs NNOX Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, NNOX has a market cap of 300.3M. Regarding current trading prices, NAOV is priced at $8.34, while NNOX trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas NNOX's P/E ratio is -5.18. In terms of profitability, NAOV's ROE is -0.55%, compared to NNOX's ROE of -0.31%. Regarding short-term risk, NAOV is more volatile compared to NNOX. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check NNOX's competition here
NAOV vs CLPT Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, CLPT has a market cap of 299.6M. Regarding current trading prices, NAOV is priced at $8.34, while CLPT trades at $10.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas CLPT's P/E ratio is -13.95. In terms of profitability, NAOV's ROE is -0.55%, compared to CLPT's ROE of -0.78%. Regarding short-term risk, NAOV is more volatile compared to CLPT. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check CLPT's competition here
NAOV vs NPCE Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, NPCE has a market cap of 291.6M. Regarding current trading prices, NAOV is priced at $8.34, while NPCE trades at $8.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas NPCE's P/E ratio is -10.84. In terms of profitability, NAOV's ROE is -0.55%, compared to NPCE's ROE of -1.40%. Regarding short-term risk, NAOV is more volatile compared to NPCE. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check NPCE's competition here
NAOV vs VMD Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, VMD has a market cap of 282.7M. Regarding current trading prices, NAOV is priced at $8.34, while VMD trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas VMD's P/E ratio is 21.44. In terms of profitability, NAOV's ROE is -0.55%, compared to VMD's ROE of +0.11%. Regarding short-term risk, NAOV is more volatile compared to VMD. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check VMD's competition here
NAOV vs CATX Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, CATX has a market cap of 276.1M. Regarding current trading prices, NAOV is priced at $8.34, while CATX trades at $3.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas CATX's P/E ratio is -3.02. In terms of profitability, NAOV's ROE is -0.55%, compared to CATX's ROE of -0.27%. Regarding short-term risk, NAOV is more volatile compared to CATX. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check CATX's competition here
NAOV vs RXST Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, RXST has a market cap of 272.1M. Regarding current trading prices, NAOV is priced at $8.34, while RXST trades at $7.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas RXST's P/E ratio is -8.31. In terms of profitability, NAOV's ROE is -0.55%, compared to RXST's ROE of -0.12%. Regarding short-term risk, NAOV is more volatile compared to RXST. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check RXST's competition here
NAOV vs TCMD Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, TCMD has a market cap of 271.3M. Regarding current trading prices, NAOV is priced at $8.34, while TCMD trades at $12.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas TCMD's P/E ratio is 19.63. In terms of profitability, NAOV's ROE is -0.55%, compared to TCMD's ROE of +0.07%. Regarding short-term risk, NAOV is more volatile compared to TCMD. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check TCMD's competition here
NAOV vs CERS Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, CERS has a market cap of 238.7M. Regarding current trading prices, NAOV is priced at $8.34, while CERS trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas CERS's P/E ratio is -12.45. In terms of profitability, NAOV's ROE is -0.55%, compared to CERS's ROE of -0.34%. Regarding short-term risk, NAOV is more volatile compared to CERS. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check CERS's competition here
NAOV vs MASS Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, MASS has a market cap of 232M. Regarding current trading prices, NAOV is priced at $8.34, while MASS trades at $6.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas MASS's P/E ratio is -2.72. In terms of profitability, NAOV's ROE is -0.55%, compared to MASS's ROE of -0.13%. Regarding short-term risk, NAOV is more volatile compared to MASS. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check MASS's competition here
NAOV vs BWAY Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, BWAY has a market cap of 228.7M. Regarding current trading prices, NAOV is priced at $8.34, while BWAY trades at $11.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas BWAY's P/E ratio is 55.00. In terms of profitability, NAOV's ROE is -0.55%, compared to BWAY's ROE of +0.07%. Regarding short-term risk, NAOV is more volatile compared to BWAY. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check BWAY's competition here
NAOV vs NVRO Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, NAOV is priced at $8.34, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas NVRO's P/E ratio is -1.91. In terms of profitability, NAOV's ROE is -0.55%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, NAOV is more volatile compared to NVRO. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check NVRO's competition here
NAOV vs OM Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, OM has a market cap of 220.8M. Regarding current trading prices, NAOV is priced at $8.34, while OM trades at $13.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas OM's P/E ratio is -0.66. In terms of profitability, NAOV's ROE is -0.55%, compared to OM's ROE of -0.98%. Regarding short-term risk, NAOV is more volatile compared to OM. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check OM's competition here
NAOV vs SGHT Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, SGHT has a market cap of 215.8M. Regarding current trading prices, NAOV is priced at $8.34, while SGHT trades at $3.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas SGHT's P/E ratio is -4.20. In terms of profitability, NAOV's ROE is -0.55%, compared to SGHT's ROE of -0.59%. Regarding short-term risk, NAOV is less volatile compared to SGHT. This indicates potentially lower risk in terms of short-term price fluctuations for NAOV.Check SGHT's competition here
NAOV vs QTRX Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, QTRX has a market cap of 212.8M. Regarding current trading prices, NAOV is priced at $8.34, while QTRX trades at $5.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas QTRX's P/E ratio is -2.53. In terms of profitability, NAOV's ROE is -0.55%, compared to QTRX's ROE of -0.22%. Regarding short-term risk, NAOV is more volatile compared to QTRX. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check QTRX's competition here
NAOV vs EYES Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, EYES has a market cap of 210M. Regarding current trading prices, NAOV is priced at $8.34, while EYES trades at $4.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas EYES's P/E ratio is N/A. In terms of profitability, NAOV's ROE is -0.55%, compared to EYES's ROE of -0.26%. Regarding short-term risk, NAOV is more volatile compared to EYES. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check EYES's competition here
NAOV vs CVRX Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, CVRX has a market cap of 196.4M. Regarding current trading prices, NAOV is priced at $8.34, while CVRX trades at $7.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas CVRX's P/E ratio is -3.65. In terms of profitability, NAOV's ROE is -0.55%, compared to CVRX's ROE of -0.79%. Regarding short-term risk, NAOV is more volatile compared to CVRX. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check CVRX's competition here
NAOV vs MGRM Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, MGRM has a market cap of 194.5M. Regarding current trading prices, NAOV is priced at $8.34, while MGRM trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas MGRM's P/E ratio is -10.76. In terms of profitability, NAOV's ROE is -0.55%, compared to MGRM's ROE of -1.26%. Regarding short-term risk, NAOV is more volatile compared to MGRM. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check MGRM's competition here
NAOV vs INGN Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, INGN has a market cap of 189.3M. Regarding current trading prices, NAOV is priced at $8.34, while INGN trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas INGN's P/E ratio is -6.12. In terms of profitability, NAOV's ROE is -0.55%, compared to INGN's ROE of -0.14%. Regarding short-term risk, NAOV is more volatile compared to INGN. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check INGN's competition here
NAOV vs PROF Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, PROF has a market cap of 170.4M. Regarding current trading prices, NAOV is priced at $8.34, while PROF trades at $5.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas PROF's P/E ratio is -4.69. In terms of profitability, NAOV's ROE is -0.55%, compared to PROF's ROE of -0.70%. Regarding short-term risk, NAOV is more volatile compared to PROF. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check PROF's competition here
NAOV vs ELMD Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, ELMD has a market cap of 160.2M. Regarding current trading prices, NAOV is priced at $8.34, while ELMD trades at $18.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas ELMD's P/E ratio is 24.18. In terms of profitability, NAOV's ROE is -0.55%, compared to ELMD's ROE of +0.17%. Regarding short-term risk, NAOV is more volatile compared to ELMD. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check ELMD's competition here
NAOV vs LNSR Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, LNSR has a market cap of 155.5M. Regarding current trading prices, NAOV is priced at $8.34, while LNSR trades at $13.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas LNSR's P/E ratio is -2.68. In terms of profitability, NAOV's ROE is -0.55%, compared to LNSR's ROE of +51.79%. Regarding short-term risk, NAOV is more volatile compared to LNSR. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check LNSR's competition here
NAOV vs OWLT Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, OWLT has a market cap of 147.2M. Regarding current trading prices, NAOV is priced at $8.34, while OWLT trades at $7.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas OWLT's P/E ratio is -5.53. In terms of profitability, NAOV's ROE is -0.55%, compared to OWLT's ROE of +2.12%. Regarding short-term risk, NAOV is less volatile compared to OWLT. This indicates potentially lower risk in terms of short-term price fluctuations for NAOV.Check OWLT's competition here
NAOV vs RPID Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, RPID has a market cap of 142.9M. Regarding current trading prices, NAOV is priced at $8.34, while RPID trades at $3.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas RPID's P/E ratio is -3.17. In terms of profitability, NAOV's ROE is -0.55%, compared to RPID's ROE of -0.56%. Regarding short-term risk, NAOV is more volatile compared to RPID. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check RPID's competition here
NAOV vs MXCT Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, MXCT has a market cap of 140.7M. Regarding current trading prices, NAOV is priced at $8.34, while MXCT trades at $2.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas MXCT's P/E ratio is -3.14. In terms of profitability, NAOV's ROE is -0.55%, compared to MXCT's ROE of -0.22%. Regarding short-term risk, NAOV is more volatile compared to MXCT. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check MXCT's competition here
NAOV vs TLSI Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, TLSI has a market cap of 135.6M. Regarding current trading prices, NAOV is priced at $8.34, while TLSI trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas TLSI's P/E ratio is -3.25. In terms of profitability, NAOV's ROE is -0.55%, compared to TLSI's ROE of +1.04%. Regarding short-term risk, NAOV is less volatile compared to TLSI. This indicates potentially lower risk in terms of short-term price fluctuations for NAOV.Check TLSI's competition here
NAOV vs AVR Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, AVR has a market cap of 130.5M. Regarding current trading prices, NAOV is priced at $8.34, while AVR trades at $3.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas AVR's P/E ratio is -1.01. In terms of profitability, NAOV's ROE is -0.55%, compared to AVR's ROE of -2.92%. Regarding short-term risk, NAOV is more volatile compared to AVR. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check AVR's competition here
NAOV vs BSGM Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, BSGM has a market cap of 128.1M. Regarding current trading prices, NAOV is priced at $8.34, while BSGM trades at $3.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas BSGM's P/E ratio is -7.72. In terms of profitability, NAOV's ROE is -0.55%, compared to BSGM's ROE of -35.30%. Regarding short-term risk, NAOV is less volatile compared to BSGM. This indicates potentially lower risk in terms of short-term price fluctuations for NAOV.Check BSGM's competition here
NAOV vs RCEL Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, RCEL has a market cap of 127.2M. Regarding current trading prices, NAOV is priced at $8.34, while RCEL trades at $5.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas RCEL's P/E ratio is -2.20. In terms of profitability, NAOV's ROE is -0.55%, compared to RCEL's ROE of -6.33%. Regarding short-term risk, NAOV is more volatile compared to RCEL. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check RCEL's competition here
NAOV vs ANIK Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, ANIK has a market cap of 118.4M. Regarding current trading prices, NAOV is priced at $8.34, while ANIK trades at $8.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas ANIK's P/E ratio is -9.12. In terms of profitability, NAOV's ROE is -0.55%, compared to ANIK's ROE of -0.35%. Regarding short-term risk, NAOV is more volatile compared to ANIK. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check ANIK's competition here
NAOV vs LUCD Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, LUCD has a market cap of 108M. Regarding current trading prices, NAOV is priced at $8.34, while LUCD trades at $0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas LUCD's P/E ratio is -0.85. In terms of profitability, NAOV's ROE is -0.55%, compared to LUCD's ROE of -11.07%. Regarding short-term risk, NAOV is more volatile compared to LUCD. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check LUCD's competition here
NAOV vs NSPR Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, NSPR has a market cap of 107.6M. Regarding current trading prices, NAOV is priced at $8.34, while NSPR trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas NSPR's P/E ratio is -3.19. In terms of profitability, NAOV's ROE is -0.55%, compared to NSPR's ROE of -1.31%. Regarding short-term risk, NAOV is more volatile compared to NSPR. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check NSPR's competition here
NAOV vs ICAD Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, NAOV is priced at $8.34, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas ICAD's P/E ratio is -20.37. In terms of profitability, NAOV's ROE is -0.55%, compared to ICAD's ROE of -0.17%. Regarding short-term risk, NAOV is more volatile compared to ICAD. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check ICAD's competition here
NAOV vs HYPR Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, HYPR has a market cap of 101.2M. Regarding current trading prices, NAOV is priced at $8.34, while HYPR trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas HYPR's P/E ratio is -2.41. In terms of profitability, NAOV's ROE is -0.55%, compared to HYPR's ROE of -0.74%. Regarding short-term risk, NAOV is more volatile compared to HYPR. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check HYPR's competition here
NAOV vs HJLI Comparison August 2025
NAOV plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NAOV stands at 2M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, NAOV is priced at $8.34, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NAOV currently has a P/E ratio of -0.01, whereas HJLI's P/E ratio is N/A. In terms of profitability, NAOV's ROE is -0.55%, compared to HJLI's ROE of -0.57%. Regarding short-term risk, NAOV is more volatile compared to HJLI. This indicates potentially higher risk in terms of short-term price fluctuations for NAOV.Check HJLI's competition here